Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Frontiers in Oncology
|
November 30, 2019
Enabling Precision Medicine for Rare Head and Neck Tumors: The Example of BRAF/MEK Targeting in Patients With Metastatic Ameloblastoma
Maxime Brunet, Emmanuel Khalifa, Antoine Italiano
The Oncologist
|
April 1, 2024
Are DNA Repair Gene Alterations Associated With the Response to Platinum-Based Regimen and Immune Checkpoint Inhibitors in Patients With Solid Tumors?
Clément Chabot, Antoine Italiano, Amandine Crombé, et al.
JAMA Oncology
|
May 26, 2018
Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy
Carlo Lucchesi, Emmanuel Khalifa, Yec'han Laizet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 27, 2024
Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patients
Jeanne Lena, Mélissa Alamé, Antoine Italiano, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 5, 2016
A SDHC Founder Mutation Causes Paragangliomas (PGLs) in the French Canadians: New Insights on the SDHC-Related PGL
Isabelle Bourdeau, Solange Grunenwald, Nelly Burnichon, et al.
Journal of Hematology & Oncology
|
June 27, 2018
Targeting ERBB2 mutations in solid tumors: biological and clinical implications
Sophie Cousin, Emmanuel Khalifa, Amandine Crombe, et al.
Journal of Hematology & Oncology
|
February 10, 2017
Clinical impact of extensive molecular profiling in advanced cancer patients
Sophie Cousin, Thomas Grellety, Maud Toulmonde, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 21, 2019
Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations
Julie Massé, Caroline Truntzer, Romain Boidot, et al.
Journal of Clinical Pathology
|
July 12, 2022
Idylla <i>EGFR</i> assay on extracted DNA: advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) patients
Emmanuel Khalifa, Caroline Chapusot, Benjamin Tournier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 17, 2019
Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms
Sabrina Croce, Isabelle Hostein, Teri A Longacre, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Frontiers in Oncology
|
November 30, 2019
Enabling Precision Medicine for Rare Head and Neck Tumors: The Example of BRAF/MEK Targeting in Patients With Metastatic Ameloblastoma
Maxime Brunet, Emmanuel Khalifa, Antoine Italiano
The Oncologist
|
April 1, 2024
Are DNA Repair Gene Alterations Associated With the Response to Platinum-Based Regimen and Immune Checkpoint Inhibitors in Patients With Solid Tumors?
Clément Chabot, Antoine Italiano, Amandine Crombé, et al.
JAMA Oncology
|
May 26, 2018
Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy
Carlo Lucchesi, Emmanuel Khalifa, Yec'han Laizet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 27, 2024
Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patients
Jeanne Lena, Mélissa Alamé, Antoine Italiano, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 5, 2016
A SDHC Founder Mutation Causes Paragangliomas (PGLs) in the French Canadians: New Insights on the SDHC-Related PGL
Isabelle Bourdeau, Solange Grunenwald, Nelly Burnichon, et al.
Journal of Hematology & Oncology
|
June 27, 2018
Targeting ERBB2 mutations in solid tumors: biological and clinical implications
Sophie Cousin, Emmanuel Khalifa, Amandine Crombe, et al.
Journal of Hematology & Oncology
|
February 10, 2017
Clinical impact of extensive molecular profiling in advanced cancer patients
Sophie Cousin, Thomas Grellety, Maud Toulmonde, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 21, 2019
Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations
Julie Massé, Caroline Truntzer, Romain Boidot, et al.
Journal of Clinical Pathology
|
July 12, 2022
Idylla <i>EGFR</i> assay on extracted DNA: advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) patients
Emmanuel Khalifa, Caroline Chapusot, Benjamin Tournier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 17, 2019
Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms
Sabrina Croce, Isabelle Hostein, Teri A Longacre, et al.
Page
of 2